{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:49:25Z","timestamp":1793422165667,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajic.2024.06.015","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:24:07Z","timestamp":1719512647000},"page":"1283-1288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The antimicrobial effectiveness of chlorhexidine and chlorhexidine-silver sulfadiazine-impregnated central venous catheters against the emerging fungal pathogen Candida auris"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9800-7211","authenticated-orcid":false,"given":"Nisha","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3748-5349","authenticated-orcid":false,"given":"Shanna","family":"Haughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3553-1957","authenticated-orcid":false,"given":"Sydney","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-1292","authenticated-orcid":false,"given":"Roula","family":"Antoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin G.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9018-3570","authenticated-orcid":false,"given":"Amy","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2024.06.015_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/81.9.1159","article-title":"The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies","volume":"81","author":"Maki","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajic.2024.06.015_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.1994.03510440058033","article-title":"Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality","volume":"271","author":"Pittet","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2024.06.015_bib3","series-title":"Hospital. Infections","article-title":"Infections due to infusion therapy","author":"Maki","year":"1992"},{"key":"10.1016\/j.ajic.2024.06.015_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajic.2014.11.014","article-title":"National Healthcare Safety Network report, data summary for 2013, device-associated module","volume":"43","author":"Dudeck","year":"2015","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2024.06.015_bib5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1186\/s12879-021-06871-5","article-title":"Multi-center prospective study on central line-associated bloodstream infections in 79 ICUs of China","volume":"21","author":"Zeng","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib6","unstructured":"European Centre for Disease Prevention and Control Surveillance Report for 2020; ECDC, HAI-Net patient-based data 2020."},{"key":"10.1016\/j.ajic.2024.06.015_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajic.2023.12.010","article-title":"Decreasing central line-associated bloodstream infections rates in intensive care units in 30 low- and middle-income countries: an INICC approach","volume":"52","author":"Rosenthal","year":"2024","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2024.06.015_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/11297298241242163","article-title":"Evaluating the outcome of a bundle with 11 components and the INICC multidimensional approach in decreasing rates of central line-associated bloodstream infections across nine Asian countries","author":"Rosenthal","year":"2024","journal-title":"J Vasc Access"},{"key":"10.1016\/j.ajic.2024.06.015_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00134-003-2045-z","article-title":"The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters","volume":"30","author":"Safdar","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajic.2024.06.015_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/615958","article-title":"Non-albicans Candida infection: an emerging threat","volume":"2014","author":"Deorukhkar","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof9020176","article-title":"Navigating the new reality: a review of the epidemiological, clinical, and microbiological characteristics of Candida auris, with a focus on children","volume":"9","author":"Ashkenazi-Hoffnung","year":"2023","journal-title":"J Fungi"},{"key":"10.1016\/j.ajic.2024.06.015_bib14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3201\/eid2509.190040","article-title":"Epidemiologic shift in Candidemia driven by Candida auris, South Africa, 2016-2017","volume":"25","author":"van Schalkwyk","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40588-020-00143-7","article-title":"Candida auris infection and biofilm formation: going beyond the surface","volume":"7","author":"Horton","year":"2020","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.ajic.2024.06.015_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1186\/s12879-020-05543-0","article-title":"Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mmy\/myy054","article-title":"Candida auris: the recent emergence of a multidrug-resistant fungal pathogen","volume":"57","author":"Forsberg","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.ajic.2024.06.015_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40121-022-00625-9","article-title":"Candida auris Candidemia in critically Ill, colonized patients: cumulative incidence and risk factors","volume":"11","author":"Briano","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ajic.2024.06.015_bib19","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/cid\/cix019","article-title":"Comparative efficacy of antimicrobial central venous catheters in reducing catheter-related bloodstream infections in adults: abridged cochrane systematic review and network meta-analysis","volume":"64","author":"Chong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-018-0416-4","article-title":"Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis","volume":"8","author":"Wang","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ajic.2024.06.015_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.282.6.554","article-title":"Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection","volume":"282","author":"Veenstra","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2024.06.015_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajic.2013.09.022","article-title":"Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs","volume":"42","author":"Lorente","year":"2014","journal-title":"Am J Infect Control"},{"issue":"1S Suppl 1","key":"10.1016\/j.ajic.2024.06.015_bib23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/NAN.0000000000000532","article-title":"Infusion Therapy Standards of Practice, 9th Edition","volume":"47","author":"Nickel","year":"2024","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.ajic.2024.06.015_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/ice.2022.87","article-title":"Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update","volume":"43","author":"Buetti","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2024.06.015_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13756-017-0269-x","article-title":"Anti-Candida activity of antimicrobial impregnated central venous catheters","volume":"6","author":"Cobrado","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2024.06.015_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/dkg361","article-title":"Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model","volume":"52","author":"Gaonkar","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.06.015_bib27","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/AAC.01622-05","article-title":"Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters","volume":"50","author":"Hanna","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2024.06.015_bib28","unstructured":"Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). Antifungal Susceptibility Testing and Interpretation; 2020. Accessed April 23, 2024. https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/antifungal-susceptibility-testing.html."},{"key":"10.1016\/j.ajic.2024.06.015_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ajic.2024.06.015_bib30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2024.06.015_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00143-X","article-title":"Emergence of resistant Candida auris","volume":"4","author":"Nelson","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ajic.2024.06.015_bib32","unstructured":"Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). Tracking Candida auris; 2023. Accessed April 24, 2024. https:\/\/www.cdc.gov\/candida-auris\/tracking-c-auris\/."},{"key":"10.1016\/j.ajic.2024.06.015_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2024.06.015_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-143-8-200510180-00007","article-title":"Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial","volume":"143","author":"Rupp","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2024.06.015_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-127-4-199708150-00001","article-title":"Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial","volume":"127","author":"Maki","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2024.06.015_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00134-004-2221-9","article-title":"Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial","volume":"30","author":"Brun-Buisson","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajic.2024.06.015_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00520-005-0812-9","article-title":"Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial","volume":"13","author":"Ostendorf","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ajic.2024.06.015_bib38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/AAC.45.5.1535-1538.2001","article-title":"Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo","volume":"45","author":"Bassetti","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2024.06.015_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.281.3.261","article-title":"Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis","volume":"281","author":"Veenstra","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2024.06.015_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0195-6701(97)90184-5","article-title":"Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial","volume":"37","author":"Logghe","year":"1997","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2024.06.015_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jac\/37.2.315","article-title":"Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters","volume":"37","author":"Bach","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.06.015_bib42","series-title":"Disinfection, Sterilization, and Preservation","first-page":"321","author":"Block","year":"2001"},{"key":"10.1016\/j.ajic.2024.06.015_bib43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2302.161320","article-title":"Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris","volume":"23","author":"Sherry","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.015_bib44","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/myc.12699","article-title":"In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris","volume":"60","author":"Abdolrasouli","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ajic.2024.06.015_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhin.2017.08.019","article-title":"Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris","volume":"97","author":"Moore","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2024.06.015_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(97)10006-X","article-title":"Intravascular-catheter-related infections","volume":"351","author":"Raad","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2024.06.015_bib47","series-title":"StatPearls","article-title":"Central line\u2013associated blood stream infections","author":"Haddadin","year":"2022"},{"key":"10.1016\/j.ajic.2024.06.015_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archinte.164.8.842","article-title":"Catheter-associated infections: pathogenesis affects prevention","volume":"164","author":"Trautner","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajic.2024.06.015_bib49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00134-003-2093-4","article-title":"Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients","volume":"30","author":"Carrasco","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajic.2024.06.015_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris","volume":"6","author":"Cortegiani","year":"2018","journal-title":"J Intensive Care"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324005765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324005765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:54:29Z","timestamp":1729320869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655324005765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0196655324005765"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2024.06.015","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antimicrobial effectiveness of chlorhexidine and chlorhexidine-silver sulfadiazine-impregnated central venous catheters against the emerging fungal pathogen Candida auris","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2024.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.","name":"copyright","label":"Copyright"}]}}